首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   384篇
  免费   21篇
耳鼻咽喉   4篇
儿科学   13篇
妇产科学   2篇
基础医学   40篇
口腔科学   1篇
临床医学   24篇
内科学   78篇
神经病学   19篇
特种医学   10篇
外科学   66篇
综合类   4篇
预防医学   29篇
眼科学   11篇
药学   42篇
中国医学   12篇
肿瘤学   50篇
  2023年   5篇
  2022年   10篇
  2021年   13篇
  2020年   10篇
  2019年   6篇
  2018年   9篇
  2017年   5篇
  2016年   10篇
  2015年   12篇
  2014年   5篇
  2013年   21篇
  2012年   29篇
  2011年   34篇
  2010年   11篇
  2009年   18篇
  2008年   17篇
  2007年   29篇
  2006年   25篇
  2005年   17篇
  2004年   25篇
  2003年   14篇
  2002年   19篇
  2001年   4篇
  2000年   10篇
  1999年   12篇
  1998年   5篇
  1997年   2篇
  1996年   1篇
  1995年   2篇
  1993年   4篇
  1992年   3篇
  1991年   2篇
  1990年   1篇
  1989年   1篇
  1988年   2篇
  1987年   1篇
  1985年   1篇
  1982年   2篇
  1981年   1篇
  1976年   1篇
  1974年   1篇
  1973年   2篇
  1972年   1篇
  1970年   1篇
  1967年   1篇
排序方式: 共有405条查询结果,搜索用时 9 毫秒
71.
We report a 40-year-old kidney recipient who developed disseminated nocardiosis associated with cutaneous Kaposi's sarcoma. The withdrawal of immunosuppressive therapy and prolonged antibiotic therapy, including imipenem and trimethoprim-sulfamethoxazole, resulted in a favourable outcome of both disorders. Three years later, graft function remains stable with a complete regression of skin and pulmonary abnormalities. This case report illustrates the predisposing role of immunosuppressive treatment in the occurrence of infectious and neoplastic complications observed after solid-organ transplantation.  相似文献   
72.
Radiotherapy is one of the principal modalities of rectal cancer treatment, and the ability to predict radio resistance could potentially improve survival through a targeted treatment approach. Cyclooxygenase-2 (COX-2) may protect against damage by irradiation that would justify the use of COX-2 inhibitors. The purpose of this study was to investigate the potential role of COX-2 in tumor response and outcome of patients with rectal cancer treated preoperatively with radiotherapy. Using immunohistochemistry, we examined COX-2 expression in 88 surgical specimens of rectal cancer treated preoperatively and in 26 pretherapeutic biopsies. We tested whether COX-2 expression was correlated with clinico-pathologic parameters and with survival and local recurrence. COX-2 was expressed in 50% of the pretherapeutic tumor biopsies and in 88.6% of post-irradiated surgical samples. COX-2 expression was correlated only with enhanced tumor inflammation (p = 0.03) and with tumor volume exceeding 30 cc (p = 0.05). COX-2 was not significantly correlated with patient survival, but none of the patients with COX-2 negative tumors did recur locally, whereas 80% of patients with local recurrences have COX-2 positive tumors. We conclude that COX-2 expression is overexpressed in the majority of rectal cancers treated with radiotherapy and likely plays a role in local relapse.  相似文献   
73.
74.
75.

Background

In this analysis we compared quality-adjusted survival outcomes between nab-paclitaxel (nab-P) and standard paclitaxel (Pac) using data from the nab-P phase III registration trial in metastatic breast cancer.

Patients and Methods

Quality-adjusted overall survival was estimated using the quality-adjusted time without symptoms or toxicity (Q-TWiST) approach. Overall survival was partitioned into time without progression/Grade ≥ 3 adverse events (AEs) toxicity (TWiST), time with Grade ≥ 3 AE toxicity (TOX), and time after relapse (REL). Q-TWiST was calculated by multiplying mean time in each health state by its assigned utility (base-case utility values: time without symptoms of disease progression or toxicity of Grade ≥ 3 adverse events [TWiST] = 1.0, TOX = 0.5, and REL = 0.5). In threshold analyses, TOX and REL varied from 0.0 to 1.0 whereas TWiST was maintained at 1.0. Comparisons were made for the intent-to-treat population and the subset of patients initiating the study drugs as second or subsequent lines (2L+) of chemotherapy (per approved nab-P indication; 2L+ subpopulation). A ≥ 15% relative Q-TWiST gain (vs. mean Pac overall survival) was considered clearly clinically important.

Results

In the intent-to-treat population, nab-P (n = 229) versus Pac (n = 225) resulted in nonsignificant gains of 1.4 months of mean Q-TWiST (11.6 vs. 10.2 months; 95% confidence interval [CI], ?0.03 to 2.8). In the 2L+ subpopulation, nab-P (n = 132) versus Pac (n = 136) resulted in a statistically significant gain of 2.2 months of mean Q-TWiST (10.5 vs. 8.4 months; 95% CI, 0.6-3.8), with a 17.1% relative Q-TWiST gain (threshold analysis range, 14.0%-19.5%, both figures significant).

Conclusion

In its approved indication for metastatic breast cancer, nab-P showed a statistically significant and clearly clinically important improvement in quality-adjusted survival time versus Pac in the 2L+ subpopulation.  相似文献   
76.
77.
78.
79.
Hairy poly(butyl acrylate) (PBuA) core‐shell particles with a crosslinked shell were prepared by soap‐free emulsion polymerization. The incorporation of the hairy structure was obtained either by surface polymerization of a methacrylate (MMA) terminated poly(ethylene oxide) (PEO), or by physical adsorption of poly(ethylene oxide)‐poly(propylene oxide) (PPO)‐poly(ethylene oxide) triblock copolymers. The particle shell was crosslinked during the synthesis so as to keep the integrity and morphology of the particle upon curing the epoxy network. Particle sizes and size distributions were determined both by quasi‐elastic light scattering and transmission electron microscopy. Particle morphology was investigated by electron and atomic force microscopies. The presence of the poly(ethylene oxide) layer was evidenced by direct analysis of the latexes by means of 1H NMR spectroscopy. Mixing of the core shell rubber particles with the reactive epoxy and processing of the toughened‐epoxy networks are described. The influence of the hairy layer (with regards to density and PEO chain length) on particle dispersion within the epoxy network, the resulting rheological behaviour of the core‐shell (CS)/prepolymer epoxy blends, and mechanical properties of the modified epoxy were examined and discussed.  相似文献   
80.
In order to examine the effect of Arbutus unedo extract on the development of genetic hypertension, three groups of six male spontaneously hypertensive rats (SHR) from 4 to 10 weeks of age, received orally an aqueous extract of the root of this Ericaceae plant at doses of 5, 50 and 250 mg/kg/24 h. The fourth group (n = 6) received tap water only and served as a control. A significant (p < 0.01) reduction of indirect systolic blood pressure (BP) was observed after 4 weeks of treatment with the two highest doses but this effect attenuated 2 weeks later. The continuous measurement of direct BP in conscious 10-week-old rats indicated that chronic treatment with Arbutus did not significantly alter the BP level, the heart rate (HR), the cardiac baroreflex sensitivity and the sympathetic nervous and renin– angiotensin system activities. In contrast, Arbutus (50 mg/kg/24 h) attenuated the pressor responses to phenylephrine and angiotensin I. Finally, a diuretic effect was evidenced in the group receiving the highest dose. It is concluded that chronic oral administration of Arbutus unedo slowly delayed the development of hypertension but did not alter the final level of BP and HR in the SHR. The vascular and renal effects of this plant, which may account for its use in folk medicine, require a more detailed analysis. © 1998 John Wiley & Sons, Ltd.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号